# A Study of 18F-AV-45 in Healthy Volunteers

> **NCT01564706** · PHASE1 · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 9 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** florbetapir F 18

## Key facts

- **NCT ID:** NCT01564706
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2012-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01564706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01564706, "A Study of 18F-AV-45 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01564706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*